NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Nia Therapeutics

Nia Therapeutics

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://niatherapeutics.com/

Last Round

Early Stage

VC

Mar 6, 2026

Total Funding Raised

$20.94M

Momentum Score

25 /100

Company Overview

Nia Therapeutics is a medical devices and equipment company that develops an implantable brain-computer interface designed to restore memory function in patients with memory loss from brain injury.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Biotechnology, Health IoT, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts, Hardware Sales

AI Layer

Application

Keywords

brain-computer interfaceBCImemory loss treatmentneural implantclosed-loop neuromodulationTBItraumatic brain injuryneurotechAI medical devicebrain implantmemory restorationneuromodulationpersonalized stimulationneural data platformClass III medical deviceAlzheimer's diseasemild cognitive impairment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nia Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nia Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMar 6, 2026
GrantAug 23, 2023
Series ADec 22, 2021
SeedOct 31, 2018

Key People

Founding team and executive leadership

Michael Kahana

Chief Executive Officer, Chair Of Scientific Advisory Board And Co-Founder

Founding Team

Dan Rizzuto

CTO

Executive Team

Nia Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 22, 2021

    $19M round completed.

Nia Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nia Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nia Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range19
Year Founded2020
Last FundingMar 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.